ZEB1 and atrial fibrillation: Recent research on cardiomyogenic differentiation of human amniotic fluid-derived mesenchymal stem cells confirmed that Zeb can potentially be used as a cardiomyogenic differentiation inducer in AF-MSCs, which could cause various genetic and epigenetic changes resulting in global chromatin remodeling57.